IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Infinium Pharmachem IPO is a book build IPO listing on NSE EMERGE exchange. The company is based in Anand and caters to Pharmaceutical sector. Swastika Investmart is the merchant banker of Infinium Pharmachem IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 17th February 2023.
Infinium Pharmachem IPO open date is 31st March 2023 and close date is 5th April 2023. IPO Allotment Date is 11th April 2023 and Listing date is 17th April 2023.Infinium Pharmachem IPO size is Rs 25.26 Cr. crores with IPO price of Rs 135.00 Cr.. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Swastika Investmart Limited is the book-running lead manager of the Infinium Pharmachem IPO. Bigshare Services Private Limited is the Registrar and Market Maker is Swastika Investmart Limited for Infinium Pharmachem IPO.
Infinium Pharmachem IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Infinium Pharmachem IPO, based in Anand, operates in the Pharmaceutical sector with a focus on Pharmaceutical & Healthcare provider. The company is launching its SME IPO on the NSE EMERGE exchange, using the Fixed Price Issue method. Infinium Pharmachem IPO size is ₹ 25.26 Cr. Crores with fresh issue size of Rs 25.26 Cr. Crores and Offer for sale being Nil.
The IPO allotment date for Infinium Pharmachem IPO is expected to be 11th April 2023, after the finalization of basis of allotment. Investors can check Infinium Pharmachem IPO allotment status on the registrars website, Bigshare Services Private Limited. Infinium Pharmachem IPO refund dates are 12th April 2023.
Infinium Pharmachem IPO is expected to be listed on 17th April 2023.
The upper price band for the Infinium Pharmachem IPO is set at ₹ 135.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Infinium Pharmachem IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Infinium Pharmachem IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 5th April 2023. After submission, funds are blocked until the basis of allotment of Infinium Pharmachem IPO is finalised.
The merchant banker for Infinium Pharmachem IPO is Swastika Investmart Limited . Swastika Investmart Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Infinium Pharmachem IPO RHP for further details.
The registrar for Infinium Pharmachem IPO is Bigshare Services Private Limited. Investors can go to Bigshare Services Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Infinium Pharmachem IPO through their official website or helpline.
Infinium Pharmachem IPO was subscribed 1.84 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
₹ 25.26 Cr.
Avg IPO Size (Sector Based)
:
₹ 23.81 Cr.
Sector: Pharmaceutical
SME IPO so far:
34
Merchant Banker:
Swastika Investmart
SME IPO by BRLM so far:
47
City:
Anand
SME IPO so far:
3
Revenue (annualised):
₹ 116.40 cr.
PE
Ratio:
7.83x
Average Sector PE Ratio: 20.29x
Infinium Pharmachem IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Infinium Pharmachem Financial Review Page
Merchant Banker(s) of Infinium Pharmachem IPO: Swastika Investmart Limited
Infinium Pharmachem IPO subscription was 1.84 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Infinium Pharmachem IPO listed at a listing price of 141.50 against the offer price of 135.00.
The current market price of Infinium Pharmachem is 236.50.
Why Us?
